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OBJECTIVE — We aimed to establish optimal deﬁnitions for abdominal obesity and meta-
bolic syndrome (MetS) among Andean adults.
RESEARCH DESIGN AND METHODS — Among 1,448 Andean adults, we assessed
therelationshipbetweenwaistcircumferenceandsubclinicalvasculardiseaseassessedbycarotid
intima-media thickness (cIMT) and manifest cardiovascular disease (M-CVD).
RESULTS — Optimal waist circumference cutoffs to classify individuals with abnormal cIMT
orM-CVDwere97and87cminmenandwomen,respectively.Withthesecutoffs,therewas
substantialdisagreementbetweentheoriginalAmericanHeartAssociation/NationalHeart,Lung
and Blood Institute (AHA/NHLBI) and the recently updated MetS deﬁnition, particularly among
men (0.85). Subjects with MetS identiﬁed by the updated deﬁnition but not meeting the
original AHA/NHLBI MetS criteria demonstrated signiﬁcantly increased cIMT (P  0.001) com-
pared with subjects who did not meet the MetS criteria by either deﬁnition.
CONCLUSIONS — Our ﬁndings support the use of ethnic-speciﬁc waist circumference
cutoffs and the updated MetS deﬁnition in Andean adults.
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I
n contrast to the third report of the ex-
pert panel on Detection, Evaluation,
and Treatment of High Blood Choles-
terol in Adults and the original American
Heart Association/National Heart, Lung
andBloodInstitute(AHA/NHLBI)criteria
for the diagnosis of metabolic syndrome
(MetS) (1), the International Diabetes
Federation (IDF) established abdominal
obesity as a prerequisite for the diagnosis
of MetS (2) and suggested ethnic-speciﬁc
waist circumference cut points. A recent
statement by IDF/NHLBI/AHA, World
Heart Federation, International Athero-
sclerosis Society, and International Asso-
ciation for the Study of Obesity
established an updated MetS deﬁnition
(hereby referred to as the “updated deﬁ-
nition”) based on ethnic-speciﬁc waist
circumference cut points but not requir-
ing the presence of abdominal obesity as
long as at least three remainder compo-
nents were present. In the absence of data
from South Americans, waist circumfer-
ence cut-points derived from South
Asians were recommended (3), but it is
unclear whether these are truly appropri-
ate (3–6).
Weaimedtodetermine:1)theappro-
priate waist circumference cut points for
deﬁning abdominal obesity in Andean
Hispanics; 2) the agreement between the
presence of MetS diagnosed by original
AHA/NHLBI versus updated criteria and
resulting differences in MetS prevalence
estimates;and3)therelationshipbetween
both criteria and the presence of subclin-
ical and manifest vascular disease.
RESEARCH DESIGN AND
METHODS— The design and meth-
ods sections of the PREVENCION study
have been previously published (7). The
study included a large probabilistic sam-
pleofAndeanMestizosaged20–80years
from Arequipa, Peru. The study was ap-
proved by the Santa Maria Catholic Uni-
versity Human Research Committee.
Participants gave informed consent. De-
tails regarding the original AHA/NHLBI
and updated MetS deﬁnitions were previ-
ously published (3,8). In the updated
MetS deﬁnition, abdominal obesity was
deﬁned using ethnic-speciﬁc waist cir-
cumference cut points derived from ini-
tial analyses in our study. Carotid intima-
media thickness (cIMT) was measured
with high-resolution carotid ultrasonog-
raphy in the 1-cm proximal to the carotid
bulb (9).
To deﬁne cut points for abnormal
cIMT,weselectedareferencesample(n
472; 45.3% male) using the following ex-
clusion criteria: (1) coronary heart dis-
ease, heart failure, stroke, peripheral
vascular disease, or previous myocardial
infarction; (2) systolic blood pressure
140 mmHg, diastolic blood pressure
90 mmHg, antihypertensive drug treat-
ment; (3) diabetes (fasting blood glucose
126 mg/dl or pharmacologic treatment
for diabetes); (4) LDL cholesterol 130
mg/dl;(5)lipid-loweringtherapy;(6)cur-
rent smoking; and (7) BMI 30 kg/m
2.
Age-independent, sex-speciﬁc cIMT
cut points were deﬁned from the 95th
percentiles of all men and women in the
reference sample. Sex- and age-speciﬁc
cIMT cut points for high cIMT were de-
ﬁned using curve-estimation procedures
(R
2  0.95) in reference participants
based on 95
th percentiles within each de-
cade of life (10). Manifest cardiovascular
disease(M-CVD)wasdeﬁnedascoronary
heart disease, heart failure, stroke, pe-
ripheral vascular disease, previous myo-
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a vascular disease risk equivalent) (1).
We constructed receiver operator
characteristic (ROC) curves to identify
optimal waist circumference cut points as
values resulting in the largest sum of sen-
sitivity and speciﬁcity for the presence of
abnormal cIMT or M-CVD. A ﬁnal waist
circumference cut point value was de-
ﬁned for each sex as the average value
weighted for the area under the ROC
curve for each end point.
Once optimal waist circumference
cut points were deﬁned, we assessed sta-
tistical agreement between original AHA/
NHLBI and updated MetS deﬁnitions
using the -statistic. We compared cIMT
with agreement categories using AN-
COVA, adjusting for sex. Analyses are
age-standardizedtotheWorldHealthOr-
ganization standard world population
(11).
RESULTS— Characteristics of the
study population are shown in supple-
mental Table A1 (available at http://care.
diabetesjournals.org/cgi/content/full/dc09-
Figure 1—Prevalence of different categories of agreement between updated and AHA/NHLBI MetS deﬁnitions in men (n  723) and women (n 
662) (A) and mean cIMT in subjects with and without MetS according to the original AHA/NHLBI deﬁnition and the updated deﬁnition (B). B: The
left panel shows mean cIMT among subjects with (n  401) and without (n  984) MetS according to the original AHA/NHLBI deﬁnition. The
middlepanelshowsthemeancIMTamongsubjectswith(n444)andwithout(n941)MetSaccordingtotheupdatedMetSdeﬁnition.Theright
panel shows mean cIMT among subjects who do not meet the MetS criteria by any deﬁnition (“No MetS,” left bar; n  941), those who meet the
updated criteria but not the original AHA/NHLBI criteria (“Updated Criteria Only,” middle bar; n  43) and those who meet the MetS criteria by
both deﬁnitions (“Both,” right bar; n  401). Point estimates and 95% CIs (bars) are shown. All comparisons are adjusted for sex.
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for waist circumference as a predictor of
abnormal cIMT (supplemental Table A2)
ranged between 0.58–0.70. In women,
optimal waist circumference cut points to
detect an abnormal cIMT based on age-
speciﬁc cutoffs, an abnormal cIMT based
on age-independent cutoff, and M-CVD
were 86, 86, and 89 cm, respectively. In
men, corresponding optimal waist cir-
cumference cut points were 96, 99, and
96 cm. Optimal weighted–average waist
circumference cut points were 97 cm for
men and 87 cm for women. These cut
points correspond to waist-to-height ra-
tios of 0.577 and 0.560 in men and
women, respectively.
Usingthesecutoffs,theupdatedMetS
deﬁnition generated greater prevalence
estimates than the original AHA/NHLBI
deﬁnition (supplemental Table A3). The
original AHA/NHLBI and updated deﬁni-
tions differed in classifying 4.4% of men
(0.85) and 1.3% of women (
0.99) (Figure 1A). Between-sex differ-
ences in the prevalence of MetS were less
pronounced with the updated deﬁnition
than the original AHA/NHLBI deﬁnition.
Figure 1B shows sex-adjusted mean
cIMT among subjects with and without
MetS according to the original AHA/
NHLBIdeﬁnition(leftpanel),andsubjects
with and without MetS according to the
updated deﬁnition (center panel). The
right panel compares cIMT with subjects
meeting the updated but not the original
AHA/NHLBI criteria (middle bar) versus
those who do not meet the criteria by any
deﬁnition (left bar), and those who meet
thecriteriabybothdeﬁnitions(rightbar).
Either deﬁnition identiﬁed subjects with
increased cIMT. However, compared
with those who did not meet the criteria
by either deﬁnition, cIMT was signiﬁ-
cantlyhigheramongsubjectswhometthe
updated but not the original AHA/NHLBI
MetS criteria, but was highest in subjects
who met the criteria by both deﬁnitions
(P  0.001).
CONCLUSIONS — In Andean His-
panic adults, waist circumference cut
points of 97 cm in men and 87 cm in
women provide optimal discrimination
for cardiovascular risk assessment as
judged by the presence of M-CVD or in-
creased cIMT. Using these cut points in
the context of the updated MetS deﬁni-
tion,wefoundconsiderabledisagreement
between the updated and original AHA/
NHLBI deﬁnitions among men. The up-
dated criteria identiﬁed a larger
proportion of subjects. Individuals who
met only the updated MetS criteria (and
not the original AHA/NHLBI-criteria)
demonstrated higher cIMT compared
with subjects who did not have MetS by
either criteria, indicating that the more
sensitiveupdatedclassiﬁcationisnotspu-
rious but rather predictive of early vascu-
lar disease. These ﬁndings are important
because they provide preliminary deﬁni-
tions of abdominal obesity for the pur-
pose of atherosclerotic risk assessment
and they identify a useful operative MetS
deﬁnition in Andean adults until more
deﬁnitive prospective data become
available.
The lower waist circumference cut
pointsidentiﬁedamongAndeanmenmay
result from a lower body height (resulting
in lower waist circumference for any
given fat distribution and waist-to-height
ratio), from ethnic-related differences in
body fat accumulation, or from compet-
ing risk factors (unrelated to abdominal
obesity) for the development of CVD in
this population.
Our study is limited by its cross-
sectional nature and because it may not
representative of all mixed-Andean
populations.
In conclusion, our ﬁndings support
the use of ethnic-speciﬁc cutoff points for
abdominal obesity (97 cm in men and
87 cm in women) and the use of the
updated deﬁnition for the diagnosis of
MetS in Andean Hispanic adults.
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